Predictors of Drug Hypersensitivity in HIV Infected Subjects

NCT00168220 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2012-01-20

No results posted yet for this study

Summary

A case-control study to look at hypersensitive and tolerant individuals matched for HLA genetic predisposition, when considering predictors of drug hypersensitivity.The study aims to identify the immunological factors increasing the risk of drug reactions in HIV positive individuals.

Conditions

Sponsors & Collaborators

  • National Health and Medical Research Council, Australia

    collaborator OTHER
  • Monash University

    collaborator OTHER
  • The Alfred

    lead OTHER

Principal Investigators

  • Paul Cameron, Dr · The Alfred

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-08-31

Countries

  • Australia

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00168220 on ClinicalTrials.gov